Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.
Hayasaka N, Takada K, Nakamura H, Arihara Y, Kawano Y, Osuga T, Murase K, Kikuchi S, Iyama S, Emori M, Sugita S, Hasegawa T, Takasawa A, Miyanishi K, Kobune M, Kato J.
Hayasaka N, et al. Among authors: nakamura h.
Sci Rep. 2019 Apr 8;9(1):5759. doi: 10.1038/s41598-019-42300-z.
Sci Rep. 2019.
PMID: 30962488
Free PMC article.